Searched for
SUDEEP PHARMA IPO
IPO investors brace for 70 lock-in expiries worth $35 billion in three months. Do you own any?According to Nuvama Alternative & Quantitative Research, the Indian stock market is set to witness a significant wave of lock-in expiries b...- IPO investors brace for 73 lock-in expiries worth $34 billion in three months. Will your portfolio be impacted?India’s stock market is set for a wave of IPO lock-in expiries over the next three months, with shares worth $34 billion from 73 recently l...
- IPO investors brace for 83 lock-in expiries worth $55 billion in three months. Do you own any?IPO investors are bracing for a significant wave of lock-in expiries between May and August, with shares of 83 newly-listed companies value...
- Mukul Agrawal reshapes Rs 6,500-crore portfolio in Q3: Two new stocks, one exit. Do you own?Mukul Agrawal has updated his Rs 6,500-crore stock portfolio. He added Hindustan Construction and Sudeep Pharma. Agrawal reduced his stake ...
- Sudeep Pharma shares rally 8% after solid listing pop. Should you buy, sell or hold?Sudeep Pharma’s strong stock market debut turned into an early rally, with shares gaining up to 8% after listing at a nearly 24% premium to...
- Strong Start! Sudeep Pharma shares list at 24% premium over IPO priceSudeep Pharma debuted strongly on D-Street with nearly 24% listing gains, aligning with grey market expectations. The Rs 895-crore IPO saw ...
- EMS sector still a ‘Sunrise Industry’ but valuations stretched: Dipan MehtaIndia's primary market is attracting significant retail investment, with some IPOs seeing massive subscriptions. While venture-funded compa...
- Sudeep Pharma sees healthy GMP: How to check IPO allotment on MUFG Intime India and BSE?Investors will know their Sudeep Pharma IPO allotment status on Wednesday. The offering saw strong demand. Grey market activity suggests a ...
- Sudeep Pharma IPO subscribed 93.71 as on final day: Check GMP, other detailsSudeep Pharma’s Rs 895-crore IPO enters its final bidding day with strong overall demand, led by robust NII and retail participation. Despi...
- Sudeep Pharma IPO Day 2: Subscribed over 2.5x, GMP rises. Should you apply?Sudeep Pharma’s Rs 895-crore IPO has seen strong early interest, already oversubscribed on Day 1 with robust demand from retail and NII inv...
- Mukul Agrawal-backed Sudeep Pharma IPO fully booked on Day 1 amid strong GMP buzz; should you apply?Sudeep Pharma IPO: Sudeep Pharma's Rs 895 crore IPO saw full subscription on its opening day, driven by strong retail and NII demand, follo...
- Will Sudeep Pharma’s IPO stand out as a long-term growth opportunity?Sudeep Pharma plans to raise ₹95 crore for capex and expand manufacturing capacity by 50,000 tonnes by March 2026. Despite strong export re...
- Sudeep Pharma IPO: Mukul Agrawal, Prashant Jain among investors in Rs 268 crore anchor bookSudeep Pharma secured strong anchor investor participation ahead of its IPO, attracting major mutual funds, insurers and marquee investors,...
- Sudeep Pharma IPO to open tomorrow; GMP rises 22%. Should you apply?Sudeep Pharma IPO: Shares are seeing solid momentum in the grey market, trading at a 21.92% premium to the issue price of ₹593. At this GMP...
- Sudeep Pharma IPO: GMP jumps 16% ahead of November 21 launch. Check tentative listing priceSudeep Pharma’s Rs 895-crore IPO is set to open on November 21, comprising a Rs 95-crore fresh issue and an Rs 800-crore OFS. The price ban...
- Sudeep Pharma sets IPO price band at Rs 563-593; issue to open on November 21Sudeep Pharma has set a price band of Rs 563–593 for its Rs 895 crore IPO, which opens on November 21. The issue comprises a fresh issue an...
- Sebi clears 7 IPOs of PNGS Reva, Safex Chemicals, Asset Reconstruction Company and othersIndia’s IPO market remains upbeat as Sebi clears seven new public issues across jewellery, pharma, renewables, logistics, and chemicals. Ke...
- Pharma, healthcare firms eye Rs 13,000-cr IPO wave over 9 monthsIndian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs i...
- Sudeep Pharma files draft papers with Sebi to mop up funds via IPOVadodara-based Sudeep Pharma has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offe...
- Stocks in news: LIC, SBI Cards, Bharti Airtel, Zomato, Vodafone IdeaThe Board of SBI Cards has declared an interim dividend of Rs 2.5 per share for the financial year ending 2023-24. The company has also fix...
Load More
